logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Alkylating Drug class drugs

    FiltersReset Filters
    6 results

    • bendeka

      (bendamustine hydrochloride)
      Teva Pharmaceuticals USA, Inc.
      Usage: BENDEKA® is indicated for the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of rituximab treatment. Efficacy compared to first-line therapies other than chlorambucil is not established.

    • gliadel

      (carmustine)
      Arbor Pharmaceuticals
      Usage: GLIADEL Wafer is indicated for treating newly-diagnosed high-grade glioma as an adjunct to surgery and radiation, and for recurrent glioblastoma as an adjunct to surgery.

    • jelmyto

      (mitomycin)
      UroGen Pharma, Inc.
      Usage: JELMYTO® is indicated for the treatment of adult patients with low-grade Upper Tract Urothelial Cancer (LG-UTUC).

    • valchlor

      (mechlorethamine hydrochloride)
      Helsinn Therapeutics (U.S.), Inc.
      Usage: VALCHLOR is indicated for the topical treatment of Stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have previously undergone skin-directed therapy.

    • yondelis

      (Trabectedin)
      Janssen Products, LP
      Usage: YONDELIS® is indicated for treating patients with unresectable or metastatic liposarcoma or leiomyosarcoma who have previously received an anthracycline-containing regimen.

    • zepzelca

      (Lurbinectedin)
      Jazz Pharmaceuticals, Inc.
      Usage: ZEPZELCA is indicated for adult patients with metastatic small cell lung cancer (SCLC) who have disease progression following platinum-based chemotherapy. This approval is based on overall response rate and duration of response, with continued approval dependent on further confirmatory trials.